What happened
Original notice title
Vidaslim Co. MARCS-CMS 705118, July 17, 2025
From the archived source record
Based on inspectional findings and review of the product labels collected during the inspection, we have identified significant violations of the Federal Food, Drug, and Cosmetic Act (the Act) and applicable regulations. Adulterated Dietary Supplements The inspection of your facility from December 9 through December 20, 2024, identified serious violations of the FDA’s regulations for Current Good Manufacturing Practice (CGMP) in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements, under Title 21, Code of Federal Regulations (CFR), Part 111 (21 CFR Part 111). These violations cause the dietary supplements products distributed by you to be adulterated within the meaning of section 402(g)(1) of the Act [21 U.S.C. 342(g)(1)] because they have been prepared, packed, or held under conditions that do not meet CGMP requirements for dietary supplements. Your significant violations of the CGMP requirements are as follows: 1. Misbranded Dietary Supplements In addition, we reviewed your product labels collected during the inspection and have determined the Vidaslim Total Control Fat Burning Capsules, Vidaslim Mujer Hormonal Balance, Vidaslim Calma Relax Gummies, Vidaslim Flaca ACV Gummies, Vidaslim Sueños Sleep Gummies, Vidaslim 15 Day Detox, Vidaslim Gut Check Probiotic Super Greens, Vidaslim Hydroboost Pro, Vidaslim Pretty Potion Acai Berry Flavor, Vidaslim Ganas, and the tejocote root products Vidaslim 30 Day Supply and Vidaslim 90 Day Supply products you distribute are misbranded under section 403 of the Act [21 U.S.C. 343] because they do not comply with the labeling requirements for dietary supplements. Your Vidaslim Gut Check Probiotic Super Greens, Vidaslim Pretty Potion Acai Berry Flavor, and Vidaslim Ganas products are misbranded within the meaning of section 403(y) of the FD&C Act [21 U.S.C. § 343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. 9.
What the official notice says to do
Check the original notice for the instructions that apply to the named product, company, and affected lots.
Read the official notice →Status and source details
- Status recorded in the archive
- No closeout listed in FDA table
- Source checked
- Jul 16, 2026
- Record revision
- 5994c5d57943
This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.
Sources, dates, and coverage →